Inventor · disambiguated record
Martin Behe
Also filed as: BEHE MARTIN
7 granted patents·10 pending applications·40 citations·filing 2005–2024
79Inventor score
Top patents by PatentIndex Score
17 records- 0186US10130724B2Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatmentSCHERRER INST PAUL·Filed 2014·Granted Nov 20, 2018·4 cites·9 claims
- 0285US8268781B2Peptide derivatives of exendin-4GOTTHARDT MARTIN·Filed 2007·Granted Sep 18, 2012·34 cites·7 claims
- 0381US11396649B2Site-specific conjugation to antibody lysine residues with solid-phase immobilized microbial transglutaminase MTG and MTG in solutionSCHERRER INST PAUL·Filed 2017·Granted Jul 26, 2022·2 cites·23 claims
- 0477US2025161479A1Transglutaminase conjugation method and linkerSCHERRER INST PAUL·Filed 2024·Application pending·0 cites
- 0576US2024279634A1Site-specific conjugation to antibody lysine residues with solid-phase immobilized microbial transglutaminase mtg and mtg in solutionSCHERRER INST PAUL·Filed 2024·Application pending·0 cites
- 0675US2024350656A1Transglutaminase conjugation method and linkerSCHERRER INST PAUL·Filed 2024·Application pending·0 cites
- 0772US11623014B2Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatmentSCHERRER INST PAUL·Filed 2020·Granted Apr 11, 2023·0 cites·14 claims
- 0867US10953114B2Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatmentSCHERRER INST PAUL·Filed 2018·Granted Mar 23, 2021·0 cites·12 claims
- 0966US2022333093A1Site-specific conjugation to antibody lysine residues with solid-phase immobilized microbial transglutaminase mtg and mtg in solutionSCHERRER INST PAUL·Filed 2022·Application pending·0 cites
- 1065US12128110B2Transglutaminase conjugation method and linkerSCHERRER INST PAUL·Filed 2018·Granted Oct 29, 2024·0 cites·31 claims
- 1154US2025345469A1Composition comprising a rapalog and a radiolabelled gastrin analogue, in particular for use in the treatment and/or diagnosis of cckb receptor positive cancer or tumorsSCHERRER INST PAUL·Filed 2021·Application pending·0 cites
- 1253US2024245811A1Alpha radiolabeled gastrin analogue and use thereof in methods of treating cckb receptor positive diseasesSCHERRER INST PAUL·Filed 2021·Application pending·0 cites
- 1346US11649268B2Fibronectin-binding peptides for use in tumor or fibrosis diagnosis and therapyETH ZUERICH·Filed 2017·Granted May 16, 2023·0 cites·16 claims
- 1444US2022133904A1Transglutaminase conjugation method with a glycine based linkerSCHERRER INST PAUL·Filed 2020·Application pending·0 cites
- 1541US2021361735A1Minigastrin derivates, in particular for use in cck2 receptor positive tumour diagnosis and/or treatmentSCHERRER INST PAUL·Filed 2018·Application pending·0 cites
- 1640US2013095037A1Peptide derivatives of exendin-4GOTTHARDT MARTIN·Filed 2012·Application pending·0 cites
- 1736US2007041903A1Modified minigastrin analogs for oncology applicationsMAINA THEODOSIA·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Martin Behe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →